1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Kidney Cancer Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Renal Cell Carcinoma (RCC) 1.2.3 Transitional Cell Carcinoma (TCC) 1.3 Market by Application 1.3.1 Global Kidney Cancer Market Share by Application: 2020 VS 2026 1.3.2 Surgery 1.3.3 Immunotherapy 1.3.4 Chemotherapy 1.3.5 Radiation Therapy 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Kidney Cancer Market Perspective (2015-2026) 2.2 Global Kidney Cancer Growth Trends by Regions 2.2.1 Kidney Cancer Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Kidney Cancer Historic Market Share by Regions (2015-2020) 2.2.3 Kidney Cancer Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Kidney Cancer Players by Market Size 3.1.1 Global Top Kidney Cancer Players by Revenue (2015-2020) 3.1.2 Global Kidney Cancer Revenue Market Share by Players (2015-2020) 3.2 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Kidney Cancer Revenue 3.4 Global Kidney Cancer Market Concentration Ratio 3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2019 3.5 Key Players Kidney Cancer Area Served 3.6 Key Players Kidney Cancer Product Solution and Service 3.7 Date of Enter into Kidney Cancer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Kidney Cancer Breakdown Data by Type (2015-2026) 4.1 Global Kidney Cancer Historic Market Size by Type (2015-2020) 4.2 Global Kidney Cancer Forecasted Market Size by Type (2021-2026) 5 Kidney Cancer Breakdown Data by Application (2015-2026) 5.1 Global Kidney Cancer Historic Market Size by Application (2015-2020) 5.2 Global Kidney Cancer Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Kidney Cancer Market Size (2015-2026) 6.2 North America Kidney Cancer Market Size by Type (2015-2020) 6.3 North America Kidney Cancer Market Size by Application (2015-2020) 6.4 North America Kidney Cancer Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Kidney Cancer Market Size (2015-2026) 7.2 Europe Kidney Cancer Market Size by Type (2015-2020) 7.3 Europe Kidney Cancer Market Size by Application (2015-2020) 7.4 Europe Kidney Cancer Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Kidney Cancer Market Size (2015-2026) 8.2 China Kidney Cancer Market Size by Type (2015-2020) 8.3 China Kidney Cancer Market Size by Application (2015-2020) 8.4 China Kidney Cancer Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Kidney Cancer Market Size (2015-2026) 9.2 Japan Kidney Cancer Market Size by Type (2015-2020) 9.3 Japan Kidney Cancer Market Size by Application (2015-2020) 9.4 Japan Kidney Cancer Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Kidney Cancer Market Size (2015-2026) 10.2 Southeast Asia Kidney Cancer Market Size by Type (2015-2020) 10.3 Southeast Asia Kidney Cancer Market Size by Application (2015-2020) 10.4 Southeast Asia Kidney Cancer Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Kidney Cancer Introduction 11.1.4 Merck Revenue in Kidney Cancer Business (2015-2020)) 11.1.5 Merck Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Kidney Cancer Introduction 11.2.4 Novartis Revenue in Kidney Cancer Business (2015-2020) 11.2.5 Novartis Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Kidney Cancer Introduction 11.3.4 AstraZeneca Revenue in Kidney Cancer Business (2015-2020) 11.3.5 AstraZeneca Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Kidney Cancer Introduction 11.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2015-2020) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Kidney Cancer Introduction 11.5.4 Pfizer Revenue in Kidney Cancer Business (2015-2020) 11.5.5 Pfizer Recent Development 11.6 Roche 11.6.1 Roche Company Details 11.6.2 Roche Business Overview 11.6.3 Roche Kidney Cancer Introduction 11.6.4 Roche Revenue in Kidney Cancer Business (2015-2020) 11.6.5 Roche Recent Development 11.7 Amgen 11.7.1 Amgen Company Details 11.7.2 Amgen Business Overview 11.7.3 Amgen Kidney Cancer Introduction 11.7.4 Amgen Revenue in Kidney Cancer Business (2015-2020) 11.7.5 Amgen Recent Development 11.8 Argos Therapeutics 11.8.1 Argos Therapeutics Company Details 11.8.2 Argos Therapeutics Business Overview 11.8.3 Argos Therapeutics Kidney Cancer Introduction 11.8.4 Argos Therapeutics Revenue in Kidney Cancer Business (2015-2020) 11.8.5 Argos Therapeutics Recent Development 11.9 Aveo Pharmaceuticals 11.9.1 Aveo Pharmaceuticals Company Details 11.9.2 Aveo Pharmaceuticals Business Overview 11.9.3 Aveo Pharmaceuticals Kidney Cancer Introduction 11.9.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2015-2020) 11.9.5 Aveo Pharmaceuticals Recent Development 11.10 Bayer 11.10.1 Bayer Company Details 11.10.2 Bayer Business Overview 11.10.3 Bayer Kidney Cancer Introduction 11.10.4 Bayer Revenue in Kidney Cancer Business (2015-2020) 11.10.5 Bayer Recent Development 11.11 Exelixis 10.11.1 Exelixis Company Details 10.11.2 Exelixis Business Overview 10.11.3 Exelixis Kidney Cancer Introduction 10.11.4 Exelixis Revenue in Kidney Cancer Business (2015-2020) 10.11.5 Exelixis Recent Development 11.12 Incyte 10.12.1 Incyte Company Details 10.12.2 Incyte Business Overview 10.12.3 Incyte Kidney Cancer Introduction 10.12.4 Incyte Revenue in Kidney Cancer Business (2015-2020) 10.12.5 Incyte Recent Development 11.13 Allergan 10.13.1 Allergan Company Details 10.13.2 Allergan Business Overview 10.13.3 Allergan Kidney Cancer Introduction 10.13.4 Allergan Revenue in Kidney Cancer Business (2015-2020) 10.13.5 Allergan Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Renal Cell Carcinoma (RCC) Table 4. Key Players of Transitional Cell Carcinoma (TCC) Table 5. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Kidney Cancer Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Kidney Cancer Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Kidney Cancer Market Share by Regions (2015-2020) Table 9. Global Kidney Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Kidney Cancer Market Share by Regions (2021-2026) Table 11. Kidney Cancer Market Market Trends Table 12. Kidney Cancer Market Drivers Table 13. Kidney Cancer Market Challenges Table 14. Kidney Cancer Market Restraints Table 15. Global Kidney Cancer Revenue by Players (2015-2020) (US$ Million) Table 16. Global Kidney Cancer Market Share by Players (2015-2020) Table 17. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2019) Table 18. Global Kidney Cancer by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Kidney Cancer Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Kidney Cancer Market Size by Type (2015-2020) (US$ Million) Table 23. Global Kidney Cancer Market Size Share by Type (2015-2020) Table 24. Global Kidney Cancer Revenue Market Share by Type (2021-2026) Table 25. Global Kidney Cancer Market Size Share by Application (2015-2020) Table 26. Global Kidney Cancer Market Size by Application (2015-2020) (US$ Million) Table 27. Global Kidney Cancer Market Size Share by Application (2021-2026) Table 28. North America Kidney Cancer Market Size by Type (2015-2020) (US$ Million) Table 29. North America Kidney Cancer Market Share by Type (2015-2020) Table 30. North America Kidney Cancer Market Size by Application (2015-2020) (US$ Million) Table 31. North America Kidney Cancer Market Share by Application (2015-2020) Table 32. North America Kidney Cancer Market Size by Country (US$ Million) (2015-2020) Table 33. North America Kidney Cancer Market Share by Country (2015-2020) Table 34. Europe Kidney Cancer Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Kidney Cancer Market Share by Type (2015-2020) Table 36. Europe Kidney Cancer Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Kidney Cancer Market Share by Application (2015-2020) Table 38. Europe Kidney Cancer Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Kidney Cancer Market Share by Country (2015-2020) Table 40. China Kidney Cancer Market Size by Type (2015-2020) (US$ Million) Table 41. China Kidney Cancer Market Share by Type (2015-2020) Table 42. China Kidney Cancer Market Size by Application (2015-2020) (US$ Million) Table 43. China Kidney Cancer Market Share by Application (2015-2020) Table 44. China Kidney Cancer Market Size by Region (US$ Million) (2015-2020) Table 45. China Kidney Cancer Market Share by Region (2015-2020) Table 46. Japan Kidney Cancer Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Kidney Cancer Market Share by Type (2015-2020) Table 48. Japan Kidney Cancer Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Kidney Cancer Market Share by Application (2015-2020) Table 50. Japan Kidney Cancer Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Kidney Cancer Market Share by Country (2015-2020) Table 52. Southeast Asia Kidney Cancer Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Kidney Cancer Market Share by Type (2015-2020) Table 54. Southeast Asia Kidney Cancer Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Kidney Cancer Market Share by Application (2015-2020) Table 56. Southeast Asia Kidney Cancer Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Kidney Cancer Market Share by Country (2015-2020) Table 58. Merck Company Details Table 59. Merck Business Overview Table 60. Merck Product Table 61. Merck Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 62. Merck Recent Development Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Product Table 66. Novartis Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 67. Novartis Recent Development Table 68. AstraZeneca Company Details Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Product Table 71. AstraZeneca Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 72. AstraZeneca Recent Development Table 73. Bristol-Myers Squibb Company Details Table 74. Bristol-Myers Squibb Business Overview Table 75. Bristol-Myers Squibb Product Table 76. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 77. Bristol-Myers Squibb Recent Development Table 78. Pfizer Company Details Table 79. Pfizer Business Overview Table 80. Pfizer Product Table 81. Pfizer Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 82. Pfizer Recent Development Table 83. Roche Company Details Table 84. Roche Business Overview Table 85. Roche Product Table 86. Roche Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 87. Roche Recent Development Table 88. Amgen Company Details Table 89. Amgen Business Overview Table 90. Amgen Product Table 91. Amgen Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 92. Amgen Recent Development Table 93. Argos Therapeutics Business Overview Table 94. Argos Therapeutics Product Table 95. Argos Therapeutics Company Details Table 96. Argos Therapeutics Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 97. Argos Therapeutics Recent Development Table 98. Aveo Pharmaceuticals Company Details Table 99. Aveo Pharmaceuticals Business Overview Table 100. Aveo Pharmaceuticals Product Table 101. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 102. Aveo Pharmaceuticals Recent Development Table 103. Bayer Company Details Table 104. Bayer Business Overview Table 105. Bayer Product Table 106. Bayer Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 107. Bayer Recent Development Table 108. Exelixis Company Details Table 109. Exelixis Business Overview Table 110. Exelixis Product Table 111. Exelixis Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 112. Exelixis Recent Development Table 113. Incyte Company Details Table 114. Incyte Business Overview Table 115. Incyte Product Table 116. Incyte Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 117. Incyte Recent Development Table 118. Allergan Company Details Table 119. Allergan Business Overview Table 120. Allergan Product Table 121. Allergan Revenue in Kidney Cancer Business (2015-2020) (US$ Million) Table 122. Allergan Recent Development Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Global Kidney Cancer Market Share by Type: 2020 VS 2026 Figure 2. Renal Cell Carcinoma (RCC) Features Figure 3. Transitional Cell Carcinoma (TCC) Features Figure 4. Global Kidney Cancer Market Share by Application: 2020 VS 2026 Figure 5. Surgery Case Studies Figure 6. Immunotherapy Case Studies Figure 7. Chemotherapy Case Studies Figure 8. Radiation Therapy Case Studies Figure 9. Kidney Cancer Report Years Considered Figure 10. Global Kidney Cancer Market Size (US$ Million), YoY Growth 2015-2026 Figure 11. Global Kidney Cancer Market Share by Regions: 2020 VS 2026 Figure 12. Global Kidney Cancer Market Share by Regions (2021-2026) Figure 13. Global Kidney Cancer Market Share by Players in 2019 Figure 14. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2019 Figure 16. North America Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. United States Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Canada Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Europe Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Asia-Pacific Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Latin America Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Middle East & Africa Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Kidney Cancer Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Merck Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 44. Novartis Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 45. AstraZeneca Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 47. Pfizer Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 48. Roche Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 49. Amgen Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 50. Argos Therapeutics Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 51. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 52. Bayer Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 53. Exelixis Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 54. Incyte Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 55. Allergan Revenue Growth Rate in Kidney Cancer Business (2015-2020) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Merck Novartis AstraZeneca Bristol-Myers Squibb Pfizer Roche Amgen Argos Therapeutics Aveo Pharmaceuticals Bayer Exelixis Incyte Allergan